Table 4 Rate of patients with preoperative elevated tumor marker CA19-9.
From: Tumor markers as a diagnostic key for hilar cholangiocarcinoma
Variable | Group A (CEA ≤ 14.4 ng/ml) | Group B (CEA > 14.4 ng/ml) | p-value |
|---|---|---|---|
N = | 119 | 17 | |
CEA | 3.3 ± 2.6 | 56 ± 62 | 0.0004 |
(Mean/±) | |||
CEA (ng/ml) | 2.4 (0-14) | 8.1 (0.5-60) | |
(Mean/range) | |||
Mean survival | 22 ± 26 | 14 ± 17 | > 0.05 |
(Months/±) | |||
Median survival | 11 (2 to 35) | 8 (3 to 15) | |
(Months/IQR) | |||
Nonresectable | 35 (29%) | 9 (53%) | 0.008 |